Toni K. Choueiri, MD of the Dana-Farber Cancer Institute discusses the changes in first line kidney cancer treatment for 2018 at the  12th European International Kidney Cancer Symposium 2017
Toni K. Choueiri, MD of the Dana-Farber Cancer Institute discusses the changes in first line kidney cancer treatment for 2018 at the  12th European International Kidney Cancer Symposium 2017